Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K/Akt signaling

Lai, L; Shen, QP; Wang, YJ; Chen, LT; Lai, JJ; Wu, ZB; Jiang, H

Wu, ZB; Jiang, H (corresponding author), Zhejiang Hosp, Dept Oncol, 12 Lingyin Rd, Hangzhou 310013, Zhejiang, Peoples R China.

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021; 419 ():

Abstract

Lung cancer is considered the main cause of cancer mortality worldwide. Osimertinib, a third-generation EGFRTKI, has been approved and administrated f......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索